China SXT Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	11	3	5	29	13	153	-	-
Market Cap Growth	-	-37.26%	-83.45%	124.46%	-91.71%	-	-	-
Enterprise Value	2	-11	-10	14	11	144	-1	0
PE Ratio	-0.10	-0.50	-0.82	-10.39	-1.24	99.69	-	-
PS Ratio	356.13	88.15	13.93	32.26	38.49	723.29	-	-
PB Ratio	2.10	0.20	0.29	1.79	1.35	13.82	-	-
P/FCF Ratio	-8.69	-19.57	22.95	-20.25	24.11	-426.71	-	-
P/OCF Ratio	-12.65	-36.70	17.61	-21.68	13.61	641.53	-	-
EV/Sales Ratio	78.24	-316.71	-30.71	15.42	31.99	680.54	-0.44	0.32
EV/EBITDA Ratio	0.52	2.07	2.06	-13.93	-1.58	73.01	-0.33	0.14
EV/EBIT Ratio	0.50	1.95	1.94	-10.30	-1.50	80.36	-0.35	0.15
EV/FCF Ratio	42.70	70.31	-50.61	-9.68	20.03	-401.49	-0.65	2.08
Debt / Equity Ratio	0.62	0.26	0.12	0.00	0.72	0.03	0.12	0.16
Debt / EBITDA Ratio	-0.24	-0.73	-0.41	-0.04	-1.00	0.15	0.22	0.18
Debt / FCF Ratio	-19.48	-24.81	9.94	-0.03	12.74	-0.84	0.43	2.65
Quick Ratio	1.40	1.29	1.20	1.07	1.11	2.19	0.90	1.11
Current Ratio	1.47	1.35	1.31	1.25	1.60	2.47	1.40	1.37
Asset Turnover	0.00	0.00	0.01	0.03	0.02	0.02	0.20	-
Interest Coverage	-31.95	-11.45	-146.38	-0.82	-2.10	347.24	2090.45	40.12
Return on Equity (ROE)	-141.60%	-38.10%	-35.40%	-21.70%	-100.30%	21.40%	46.20%	-
Return on Assets (ROA)	-76.90%	-18.80%	-16.80%	-9.80%	-52.50%	12.30%	18.10%	-
Return on Capital (ROIC)	-161.94%	-24.15%	-25.72%	-13.83%	-7.79%	-1.73%	62.92%	90.19%
Earnings Yield	-132.67%	-200.25%	-121.43%	-9.63%	-80.89%	1.00%	-	-
FCF Yield	-1.52%	-5.11%	4.36%	-4.94%	4.15%	-0.23%	-	-
Buyback Yield / Dilution	-1512.49%	-541.90%	-44.50%	-132.79%	-20.23%	-2.84%	-	-
Total Shareholder Return	-1512.49%	-541.90%	-44.50%	-132.79%	-20.23%	-2.84%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).